141.
Aspirin: still learning about the wonder drug
by Hawk, E T
Gut, 2003-11, Vol.52 (11), p.1535-1536
142.
Chemomodulatory action of Aloe vera on the profiles of enzymes associated with carcinogen metabolism and antioxidant status regulation in mice
by Singh, Rana P
Phytomedicine (Stuttgart), 2000, Vol.7 (3), p.209-219
143.
Successful Treatment of Sclerosing Cervicitis and Fibrosing Mediastinitis With Tamoxifen
by Savelli, Brent A
Chest, 1997-04, Vol.111 (4), p.1137-1140
144.
Risk estimation for breast cancer development; a clinical perspective
by Sakorafas, George H
Surgical oncology, 2002, Vol.10 (4), p.183-192
145.
Post-initiation effects of a super critical extract of propolis in a rat two-stage carcinogenesis model in female F344 rats
by Kimoto, Naoya
Cancer letters, 1999, Vol.147 (1), p.221-227
146.
Combination of Bexarotene and Psoralen-UVA Therapy in a Patient with Mycosis fungoides
by Michaelis, S
Dermatology (Basel), 2004-07, Vol.209 (1), p.72-74
147.
148.
TAC-101 inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma
by Lee, Soo Jin
Cancer letters, 2003, Vol.198 (2), p.169-177
149.
Potential Agents for Prostate Cancer Chemoprevention
by Brawley, Otis W
Epidemiologic reviews, 2001, Vol.23 (1), p.168-172
150.
Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat
by SHENGMIN LI
Breast cancer research and treatment, 1994, Vol.29 (2), p.203-217
151.
Retinoids and cancer prevention
by HILL, D. L
Annual review of nutrition, 1992, Vol.12 (1), p.161-181
152.
In vivo and in vitro percutaneous absorption of cancer preventive flavonoid apigenin in different vehicles in mouse skin
by LI, B
Pharmaceutical research, 1996, Vol.13 (11), p.1710-1715
153.
Long-term administration of galactoside-specific mistletoe lectin in an animal model : no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinog...
by KUNZE, E
Journal of cancer research and clinical oncology, 2000, Vol.126 (3), p.125-138
154.
Dose-related preventive and therapeutic effects of antioxidants-anticarcinogens on experimentally induced malignant tumors in Wistar rats
by Evangelou, A
Cancer letters, 1997, Vol.115 (1), p.105-111
155.
Chemopreventive effects of sage oil on skin papillomas in mice
by Gali-Muhtasib, H.U
Phytomedicine (Stuttgart), 2000, Vol.7 (2), p.129-136
156.
Plant Sources of Vitamin A and Human Nutrition: Red Palm Oil Does the Job
by Solomons, Noel W
Nutrition reviews, 1998-10, Vol.56 (10), p.309-311
157.
Pharmacologic response of a controlled-release PLGA formulation for the alpha-melanocyte stimulating hormone analog, Melanotan-I
by BHARDWAJ, R
Pharmaceutical research, 2000, Vol.17 (5), p.593-599
158.
Failure of phenethyl isothiocyanate to inhibit hamster tumorigenesis induced by N-nitrosobis(2-oxopropyl)amine when given during the post-initiation phase
by Nishikawa, Akiyoshi
Cancer letters, 1999, Vol.141 (1), p.109-115
159.
Effects of Oral Bexarotene (Targretin®) on the Minimal Erythema Dose for Broadspectrum UVB Light
by Smit, J.V
Skin pharmacology and applied skin physiology, 2003-08, Vol.16 (4), p.237-241
160.
The Vitamin D and Cancer Conundrum: Aiming at a Moving Target
by Toner, Cheryl D., MS, RD
Journal of the American Dietetic Association, 2010, Vol.110 (10), p.1492-1500
